由特定离子同活性效应触发的可编程有效载荷释放
Shijia Tang1, Liuyan Tang1, Xiaocun Lu1
1Beckman Institute for Advanced Science and Technology, ‡Department of Materials Science and Engineering, and ∥Department of Chemistry, University of Illinois at Urbana-Champaign , Urbana, Illinois 61801, United States.
Journal of the American Chemical Society
|December 13, 2017
概括
研究人员在过渡性聚合物中发现了一种特定的离子联合激活 (SICA) 效应. 这一发现使得可编程的微囊能够使用特定的离子组合进行受控的释放.
科学领域:
- 材料科学
- 聚合物化学
- 超分子化学
背景情况:
- 响应刺激的材料对于化学逻辑门和信号放大至关重要.
- 在材料中表征同活性反应仍然是一个挑战.
研究的目的:
- 在过渡性聚合物固体中证明和描述特定的离子同活性化 (SICA) 作用.
- 开发基于SICA效应的可编程微囊.
主要方法:
- 在含有各种离子的酸性甲醇溶液中研究循环聚甲 (cPPA) 核心外微的脱聚合.
- 分析了阴离子和离子对脱聚率的影响,并将其与霍夫迈斯特行为相关联.
主要成果:
- 通过酸和特定离子联合激活后观察到cPPA脱聚变的显著加速.
- 发现SICA效应主要由阴离子控制,而阴离子则起到次要的调节作用.
- 开发的cPPA微囊具有可编程的有效载荷释放率,取决于盐和酸甲醇溶液的组成.
结论:
- SICA效应提供了一种控制过渡性聚合物降解的新机制.
- 这项研究为设计先进的响应材料和智能交付系统奠定了基础.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
17
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
17
Modified-Release Drug Delivery Systems: Rate-Programmed II
6
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
6
Site-Targeted Drug Delivery Systems: Polymeric Carriers
17
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
17
Modified-Release Drug Delivery Systems: Rate-Programmed I
17
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
17
Modified-Release Drug Delivery Systems: Classification
21
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
21
Modified-Release Drug Delivery Systems: Site-Targeted
18
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
18


